Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Carvykti
Pharma
FDA warns of intestinal disorder risk with use of J&J's Carvykti
The FDA has adjusted the label of J&J's Carvykti, warning that use of the CAR-T could increase the risk a potentially fatal intestinal disorder.
Kevin Dunleavy
Oct 13, 2025 11:16am
Gilead reports 7% sales decline for CAR-Ts Yescarta, Tecartus
Aug 8, 2025 11:40am
J&J, Legend debut first TV ad for multiple myeloma med Carvykti
Jul 30, 2025 2:56pm
FDA removes barrier to CAR-Ts; move likely to boost uptake
Jun 27, 2025 11:14am
J&J, Legend to invest $150M in Belgium cell therapy facility
Mar 12, 2025 2:15pm
Should BeiGene or Legend sell itself in 2025?
Jan 9, 2025 9:15am
